---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-073517"
form_type: "8-K"
ticker: "ADGM"
cik: "0002006986"
company_name: "Adagio Medical Holdings, Inc."
filed_at: "2026-06-12T20:32:32+00:00"
generated_at: "2026-06-12T20:53:47.901239+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Adagio Medical receives Nasdaq notice for bid price < $1; 180-day cure period until Dec 9, 2026

## Summary
- Notice from Nasdaq on June 12, 2026 for non-compliance with Listing Rule 5550(a)(2) (min $1 bid).
- Stock continues trading on Nasdaq Capital Market during 180-day cure period ending Dec 9, 2026.
- To regain compliance, bid price must close at or above $1 for at least 10 consecutive trading days.
- Second 180-day period may be available if necessary; delisting possible if non-compliance persists.
- Company considering options including reverse stock split to meet bid price requirement.

## SEC filing metadata
- accession: 0001104659-26-073517
- form_type: 8-K
- ticker: ADGM
- cik: 0002006986
- company_name: Adagio Medical Holdings, Inc.
- filed_at: 2026-06-12T20:32:32+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/0001104659-26-073517-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/tm2617882d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-073517
- JSON: https://secwatch.observer/filing/0001104659-26-073517.json
- Plain text: https://secwatch.observer/filing/0001104659-26-073517.txt

## Key facts
- Listing & Compliance Notices
  Adagio Medical Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: June 12, 2026, Adagio Medical Holdings, Inc. (the “ Company ”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that the listing of its common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market, as the minimum bid price of the Company’s common stock was less than $1.00 per share for the previous 30 consecutive business days (the “ Minimum Bid Price Requirement ”). The notification does not impact the listing of the Company’s common stock on The Nasdaq Ca
  evidence_url: https://www.sec.gov/Archives/edgar/data/2006986/000110465926073517/0001104659-26-073517-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.